| 000 | 01803 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517064432.0 | ||
| 264 | 0 | _c20160915 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1177-8881 | ||
| 024 | 7 |
_a10.2147/DDDT.S92395 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Sanctis, Rita | |
| 245 | 0 | 0 |
_aEfficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma. _h[electronic resource] |
| 260 |
_bDrug design, development and therapy _c2015 |
||
| 300 |
_a5785-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadverse effects |
| 650 | 0 | 4 |
_aDioxoles _xadverse effects |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeiomyosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aLiposarcoma _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSarcoma _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTetrahydroisoquinolines _xadverse effects |
| 650 | 0 | 4 | _aTrabectedin |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMarrari, Andrea | |
| 700 | 1 | _aMarchetti, Silvia | |
| 700 | 1 | _aMussi, Chiara | |
| 700 | 1 | _aBalzarini, Luca | |
| 700 | 1 | _aLutman, Fabio Romano | |
| 700 | 1 | _aDaolio, Primo | |
| 700 | 1 | _aBastoni, Stefano | |
| 700 | 1 | _aBertuzzi, Alexia Francesca | |
| 700 | 1 | _aQuagliuolo, Vittorio | |
| 700 | 1 | _aSantoro, Armando | |
| 773 | 0 |
_tDrug design, development and therapy _gvol. 9 _gp. 5785-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/DDDT.S92395 _zAvailable from publisher's website |
| 999 |
_c25483353 _d25483353 |
||